奇精機械(603677.SH):擬結項或終止部分募投項目 並將剩餘募集資金永久補充流動資金
格隆匯12月23日丨奇精機械(603677.SH)公佈,公司(於2021年12月23日召開第三屆董事會第二十七次會議,審議通過了《關於公司部分可轉債募投項目結項或終止並將剩餘募集資金永久補充流動資金的議案》,公司董事會同意將“年產270萬套波輪洗衣機離合器技改及擴產項目”予以結項,同意終止實施“年產400萬套滾筒洗衣機零部件擴產項目”,同時將上述募投項目結項或終止後的剩餘募集資金分別為3187.96萬元、3073.92萬元,共計6261.88萬元(含累計收到的理財收益淨額、銀行存款利息扣除銀行手續費等的淨額,具體金額以轉出時賬户實際餘額為準)永久補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.